Biology subjects

Trefry, S. V.

Publications and source records attributed to Trefry, S. V..

3 recordsLinked to original sources

bioRxiv2026

The Sustained Alteration Of Brain Waves In Cynomolgus Macaques Following Aerosol Infection With Venezuelan Equine Encephalitis Virus Subtype IAB

Venezuelan equine encephalitis virus subtype IAB (VEEV-IAB) is a mosquito-borne virus that can cause fatal encephalitis in humans and equids. During the 20th century, sporadic but widespread outbreaks occurred throughout the Americas. In addition, VEEV-IAB was investigated as a potential biological warfare agent during the Cold War. Currently, no countermeasures are available to treat or prevent human infection. A critical impediment to understanding VEEV-IAB pathogenesis and developing countermeasures is the lack of a detailed disease course in a susceptible animal model. This study evaluated VEEV-IAB disease progression in cynomolgus macaques using advanced telemetry technology to continuously monitor physiological parameters, including temperature, respiration, activity, heart rate, blood pressure, electrocardiography (ECG), and electroencephalography (EEG), following an aerosol challenge of 6.0 log10 PFU. Following infection, all parameters were altered relative to baseline; temperature (+3.1 to +4.0{degrees}C), respiration rate (+45 to +91%), activity [daytime (-29 to -55%) and nighttime (+14 to +34%)], heart rate (-27 to +191%), systolic (+11 to +39%) and diastolic blood pressure (+7 to +39%). Cardiac abnormalities included increases in QTc (Bazett), PR interval, and QRS duration. All EEG frequency bands were rapidly altered (-250% to +4,800%) and did not return to baseline during the 28-day post-infection period. Despite these profound physiological changes, brain tissues collected at 28 dpi showed minimal evidence of viral persistence or pathology. These data demonstrate that VEEV-IAB aerosol infection rapidly and markedly alters physiological parameters regulated by the autonomic nervous system, as well as provides new insights into VEEV-IAB pathogenesis and countermeasure development.

microbiology↗

bioRxiv2026

Computational and Proteomic Analyses Reveal Cardiac Dysfunction and Heart Failure-Associated Biomarker Secretion from Venezuelan Equine Encephalitis Virus TC83-infected human IPSC-derived Cardiomyocytes

Arthropod-borne pathogens, many of which are neurotropic, can disseminate beyond the central nervous system to infect peripheral organs. In recent years, an increasing number of cardiac dysfunctions have been reported following arthropod-borne viral infections; however, the mechanism underlying these cardiac manifestations remains poorly understood. In this study, we investigated the impact of Venezuelan Equine Encephalitis Virus (VEEV) TC-83 infection on cardiac function and immune-response of human induced-pluripotent stem cell (hIPSC)-derived cardiomyocytes (hIPSC-CMs). We first confirmed the successful differentiation of hIPSCs into spontaneously beating hIPSC-CMs. We then demonstrated that these cells are highly susceptible to VEEV TC-83 infection, which induced pronounced arrhythmias and complete cessation of beating within 24 hours post-infection. To quantify these functional changes, we developed a segmentation-free computational pipeline that converts frame-to-frame motion in brightfield time-lapse movies into a one-dimensional signal reflecting contractile activity and extracts beat timing, beat rate, and rhythm-regularity features in the time and frequency domains. This analysis revealed progressive disruption of beating dynamics following VEEV TC-83 infection, with early rhythm instability and complete loss of coordinated beating by 24 hours post-infection. Furthermore, mass spectrometry analysis of VEEV TC-83-infected hIPSC-CMs supernatants revealed the presence of biomarkers typically associated with heart failure in patients, underscoring a virus-induced cardiac functional impairment. Together, these findings provide new insight into cardiac complications associated with arthropod-borne viral infections and may support advances in preventive medicine.

cell biology↗

bioRxiv2025

Monkeypox Virus Clade IIb Isolate Exhibits Reduced Virulence Relative to Clade IIa Isolates in Multiple Murine Models

Monkeypox virus (MPXV) is the causative agent of mpox disease in humans. The virus is comprised of two clades, Central African clade I and West African clade II with case fatality rates of [~]11 and [~]4%, respectively. Since the discovery of mpox disease in 1970, the virus has been restricted to Africa. However, in 2022, a previously unrecognized subclade IIb caused the largest global outbreak of mpox disease with a case fatality rate of [~]0.2%. The difference in virulence of MPXV subclades in human infection warrants further investigation, however, one critical limitation is the lack of susceptible small animal models. In this study, we investigated the susceptibility of four murine models, including CAST-EiJ and three immunocompromised models (C57BL/6 Ifnar-/-, C57BL/6 Ifngr-/-, and C57BL/6 Ifnar-/-/Ifngr-/-) to MPXV clade IIa (WR 7-61 and US-2003) and IIb (MA-2022) isolates. All four mouse models were susceptible to clade IIa infection, leading to severe disease marked by decreased body temperature, weight loss, and lethality. In contrast, clade IIb infection produced minimal to mild disease at similar doses in all four murine models. The clade IIb isolate produced severe disease (40% lethality) at only the highest dose (8.0 log10 PFU) in the most susceptible immunocompromised mouse model, C57BL/6 Ifnar-/-/Ifngr-/-. This is the first demonstration of lethal disease with clade IIb in a murine model. In addition, these data demonstrate that clade IIa is [~]100- to 100,000-fold more virulent than clade IIb and provide three additional murine models for investigating MPXV infection and pathogenesis. IMPORTANCEMpox is an emerging human disease caused by four distinct MPXV subclades (Ia, Ib, IIa, and IIb). Despite genetic similarities, the case fatality rate varies considerably between the subclades: Ia ([~]11%), Ib and IIa ([~]4%), and IIb ([~]0.2%). Since 2022, multiple mpox outbreaks have occurred due to previously unrecognized subclades, leading to the declaration of two public health emergencies by the World Health Organization. This unprecedented global spread, coupled with the variation in severity of human disease, underscores the importance of research into the pathogenesis of emerging MPXV subclades. However, a critical limitation is the lack of suitable small animal models. This study identifies three additional murine models susceptible to MPXV clade II infection and demonstrates significant virulence differences between clade IIa and IIb. These models will enable rapid characterization of previously unrecognized subclades and will facilitate countermeasure development.

microbiology↗